EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analytical Validation of Quantitative Polymerase Chain Reaction and AscentTM Low-Pass Whole Genome Sequencing to Report on Gene Copy Number Variants in Cerebrospinal Fluid Tumor-Derived DNA

Viriya Keo, Sakshi Khurana, Vindhya Udhane, Alexandra Larson, Jennifer N. Adams, Daniel Sanchez, Tarin Peltier, Anthony Acevedo, Kathleen Mitchell, Kala F. Schilter, Qian Nie, Honey V. Reddi

Journal of Molecular Pathology · 12.05.2026 · 7 (2) · 18

DOI: 10.3390/jmp7020018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Pathology, online erschienen am 12.05.2026. Verfasst von Viriya Keo und 11 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evaluation of gene-level copy number variants (CNVs) for diagnosis and therapeutic decision making has become standard of care with next-generation sequencing (NGS), immunohistochemistry (IHC), and/or fluorescence in situ hybridization (FISH) being used to detect gene amplifications/deletions in tumor tissue. In contrast to most solid tumors, CNS cancers are challenging to evaluate by resection and/or biopsy due to the associated risks with invasive brain surgery that can also result in death or associated morbidity and therefore alternate methods are required.

Methods

This study presents the analytical validation of using quantitative PCR (qPCR) to detect gene CNVs directly from cerebrospinal fluid (CSF)-derived DNA and from the AscentTM low-pass whole genome sequencing (LP-WGS) libraries, demonstrating concordance with the gold standard of NGS/IHC/FISH used in tumor tissue.

Results

The analytical sensitivity of qPCR to detect gene amplification calls for ERBB2 (erb-b2 receptor tyrosine kinase 2) was demonstrated to be 100% and that of EGFR (epidermal growth factor receptor) was 83%, with specificities of 96% and 100%, respectively. The analytical sensitivity of qPCR to detect gene deletions for CDKN2A/2B (cyclin-dependent kinase inhibitor 2A/2B) was 60% and that for MTAP (methylthioadenosine phosphorylase) was 100% with a specificity of 100% for all three genes. AscentTM was demonstrated to have a higher sensitivity (100%) when compared to qPCR for the same genes evaluated and demonstrated 100% positive agreement and 100% negative agreement with known CNV status.

Conclusions

The results demonstrate that given the paucity of cells in CSF limiting the use of IHC and FISH, qPCR and AscentTM provide highly sensitive, novel, minimally invasive methods for the evaluation of gene copy number (CN) status to inform the diagnosis and management of CNS cancers.

Förderung

  • National Institutes of Health

Zitieren

APA

Keo, V., Khurana, S., Udhane, V., Larson, A., Adams, J. N., Sanchez, D., Peltier, T., Acevedo, A., Mitchell, K., Schilter, K. F., Nie, Q., & Reddi, H. V. (2026). Analytical Validation of Quantitative Polymerase Chain Reaction and AscentTM Low-Pass Whole Genome Sequencing to Report on Gene Copy Number Variants in Cerebrospinal Fluid Tumor-Derived DNA. Journal of Molecular Pathology, 7(2), 18. https://doi.org/10.3390/jmp7020018

Vancouver

Keo V, Khurana S, Udhane V, Larson A, Adams JN, Sanchez D, et al. Analytical Validation of Quantitative Polymerase Chain Reaction and AscentTM Low-Pass Whole Genome Sequencing to Report on Gene Copy Number Variants in Cerebrospinal Fluid Tumor-Derived DNA. Journal of Molecular Pathology. 2026;7(2):18. doi:10.3390/jmp7020018

BibTeX
@article{Keo2026,
  author = {Keo, Viriya and Khurana, Sakshi and Udhane, Vindhya and Larson, Alexandra and Adams, Jennifer N. and Sanchez, Daniel and Peltier, Tarin and Acevedo, Anthony and Mitchell, Kathleen and Schilter, Kala F. and Nie, Qian and Reddi, Honey V.},
  title = {Analytical Validation of Quantitative Polymerase Chain Reaction and AscentTM Low-Pass Whole Genome Sequencing to Report on Gene Copy Number Variants in Cerebrospinal Fluid Tumor-Derived DNA},
  journal = {Journal of Molecular Pathology},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {18},
  doi = {10.3390/jmp7020018}
}
Kostenlos starten →